CELU
CELU
NASDAQ · Biotechnology

Celularity Inc-A

$0.70
+0.00 (+0.07%)
As of Aug 15, 2:27 AM ET ·
Financial Highlights (FY 2026)
Revenue
30.20M
Net Income
-104,336,504
Gross Margin
24.4%
Profit Margin
-345.5%
Rev Growth
+13.9%
D/E Ratio
4.75
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 24.4% 24.4% 53.6% 53.6%
Operating Margin -274.5% -247.1% 20.6% 21.3%
Profit Margin -345.5% -328.2% 22.1% 19.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 30.20M 26.52M 10.25M 10.35M
Gross Profit 7.37M 6.47M 5.50M 5.55M
Operating Income -82,918,972 -65,531,326 2.11M 2.20M
Net Income -104,336,504 -82,457,721 2.27M 1.98M
Gross Margin 24.4% 24.4% 53.6% 53.6%
Operating Margin -274.5% -247.1% 20.6% 21.3%
Profit Margin -345.5% -328.2% 22.1% 19.1%
Rev Growth +13.9% +13.9% +24.9% +1.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 8.37M 8.37M 12.27M 11.63M
Total Equity 1.76M 1.76M 14.31M 15.01M
D/E Ratio 4.75 4.75 0.86 0.77
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -81,220,504 -67,755,074 3.06M 3.48M
Free Cash Flow 1.07M 1.08M